Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients.

MLA

Pérez-Sánchez, C., et al. “Diagnostic Potential of NETosis-Derived Products for Disease Activity, Atherosclerosis and Therapeutic Effectiveness in Rheumatoid Arthritis Patients.” Journal of Autoimmunity, vol. 82, Aug. 2017, pp. 31–40. EBSCOhost, https://doi.org/10.1016/j.jaut.2017.04.007.

APA

Pérez-Sánchez, C., Ruiz-Limón, P., Aguirre, M. A., Jiménez-Gómez, Y., Arias-de la Rosa, I., Ábalos-Aguilera, M. C., Rodriguez-Ariza, A., Castro-Villegas, M. C., Ortega-Castro, R., Segui, P., Martinez, C., Gonzalez-Conejero, R., Rodríguez-López, S., Gonzalez-Reyes, J. A., Villalba, J. M., Collantes-Estévez, E., Escudero, A., Barbarroja, N., & López-Pedrera, C. (2017). Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients. Journal of Autoimmunity, 82, 31–40. https://doi.org/10.1016/j.jaut.2017.04.007

Chicago

Pérez-Sánchez, C, P Ruiz-Limón, M A Aguirre, Y Jiménez-Gómez, I Arias-de la Rosa, M C Ábalos-Aguilera, A Rodriguez-Ariza, et al. 2017. “Diagnostic Potential of NETosis-Derived Products for Disease Activity, Atherosclerosis and Therapeutic Effectiveness in Rheumatoid Arthritis Patients.” Journal of Autoimmunity 82 (August): 31–40. doi:10.1016/j.jaut.2017.04.007.